Stock analysts at Lake Street Capital initiated coverage on shares of Alphatec Holdings, Inc. (NASDAQ:ATEC) in a research note issued to investors on Monday, October 16th, Marketbeat.com reports. The firm set a “buy” rating and a $7.00 price target on the medical technology company’s stock. Lake Street Capital’s target price indicates a potential upside of 76.77% from the company’s previous close.
A number of other equities analysts have also weighed in on the company. ValuEngine lowered Alphatec Holdings from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 17th. HC Wainwright initiated coverage on shares of Alphatec Holdings in a research report on Monday, August 14th. They set a “buy” rating and a $4.00 price target for the company.
Alphatec Holdings (NASDAQ ATEC) opened at 3.96 on Monday. The stock has a 50 day moving average of $2.96 and a 200-day moving average of $2.18. The company’s market cap is $43.74 million. Alphatec Holdings has a 12 month low of $1.58 and a 12 month high of $6.78.
Alphatec Holdings (NASDAQ:ATEC) last issued its earnings results on Thursday, August 10th. The medical technology company reported ($0.32) earnings per share for the quarter. The business had revenue of $24.38 million during the quarter. Equities research analysts expect that Alphatec Holdings will post ($1.20) EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This article was first posted by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.dispatchtribunal.com/2017/10/27/alphatec-holdings-inc-atec-coverage-initiated-at-lake-street-capital.html.
Institutional investors have recently added to or reduced their stakes in the stock. Fondren Management LP increased its holdings in Alphatec Holdings by 20.8% in the 2nd quarter. Fondren Management LP now owns 220,534 shares of the medical technology company’s stock worth $408,000 after acquiring an additional 37,933 shares in the last quarter. Sabby Management LLC purchased a new stake in Alphatec Holdings in the 2nd quarter worth approximately $629,000. Finally, Broadfin Capital LLC increased its holdings in Alphatec Holdings by 163.1% in the 2nd quarter. Broadfin Capital LLC now owns 594,533 shares of the medical technology company’s stock worth $1,100,000 after acquiring an additional 368,527 shares in the last quarter. 20.56% of the stock is owned by institutional investors.
About Alphatec Holdings
Alphatec Holdings, Inc is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures.
Receive News & Ratings for Alphatec Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alphatec Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.